Page last updated: 2024-08-21

medroxyprogesterone and Marfan Syndrome, Type I

medroxyprogesterone has been researched along with Marfan Syndrome, Type I in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hennekam, RC; le Cessie, S; Rozendaal, L; Wit, JM1
McKusick, VA; Skovby, F1

Other Studies

2 other study(ies) available for medroxyprogesterone and Marfan Syndrome, Type I

ArticleYear
Growth-reductive therapy in children with marfan syndrome.
    The Journal of pediatrics, 2005, Volume: 147, Issue:5

    Topics: Adolescent; Body Height; Child; Drug Therapy, Combination; Ethinyl Estradiol; Female; Growth Disorders; Humans; Male; Marfan Syndrome; Medroxyprogesterone; Multivariate Analysis; Regression Analysis; Retrospective Studies; Testosterone; Treatment Outcome

2005
Estrogen treatment of tall stature in girls with the Marfan syndrome.
    Birth defects original article series, 1977, Volume: 13, Issue:3C

    Topics: Adolescent; Age Determination by Skeleton; Body Height; Child; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Humans; Marfan Syndrome; Medroxyprogesterone; Menstruation; Methandrostenolone

1977